A framework for communicating the value of diagnostic products to various health care stakeholders has been released by AdvaMed, along with a report on broader assessment of the value of medtech. The diagnostic framework identifies core principles for guiding value assessments, as well as four "value drivers" that should be considered in the process: the product's clinical utility based on patient outcomes, nonclinical impact, public health or population impact and footprint on care delivery revenue and costs.
Frameworks for diagnostics, medtech value assessment released by AdvaMed
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.